These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 22752608)

  • 41. How low is too low? Cycle day 28 estradiol levels and pregnancy outcomes.
    Melnick AP; Pereira N; Murphy EM; Rosenwaks Z; Spandorfer SD
    Fertil Steril; 2016 Apr; 105(4):905-909.e1. PubMed ID: 26707516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles.
    Hu X; Luo Y; Huang K; Li Y; Xu Y; Zhou C; Mai Q
    Medicine (Baltimore); 2016 May; 95(20):e3691. PubMed ID: 27196479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Association Between Serum Estradiol Levels on hCG Trigger Day and Live Birth Rates in Non-PCOS Patients: A Retrospective Cohort Study.
    Xu X; Yang A; Han Y; Wang W; Hao G; Cui N
    Front Endocrinol (Lausanne); 2022; 13():839773. PubMed ID: 35592781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?
    Connell MT; Patounakis G; Healy MW; DeCherney AH; Devine K; Widra E; Levy MJ; Hill MJ
    Fertil Steril; 2016 Sep; 106(3):584-589.e1. PubMed ID: 27178228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve.
    Mahran A; Khairy M; Elkhateeb R; Hegazy AR; Abdelmeged A; Batiha GE; Alsharif KF; Hetta HF; Bahaa HA
    J Ovarian Res; 2021 Apr; 14(1):52. PubMed ID: 33794989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Effects of Endometrial Thickness on Pregnancy Outcomes of Fresh IVF/ICSI Embryo Transfer Cycles: An Analysis of Over 40,000 Cycles Among Five Reproductive Centers in China.
    Xu J; Zhang S; Jin L; Mao Y; Shi J; Huang R; Han X; Liang X; Zhang C
    Front Endocrinol (Lausanne); 2021; 12():788706. PubMed ID: 35140680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of ICSI in IVF cycles in women with tubal ligation does not improve pregnancy or live birth rates.
    Grimstad FW; Nangia AK; Luke B; Stern JE; Mak W
    Hum Reprod; 2016 Dec; 31(12):2750-2755. PubMed ID: 27738114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve.
    Lin MH; Wu FS; Hwu YM; Lee RK; Li RS; Li SH
    Reprod Biol Endocrinol; 2019 Jan; 17(1):7. PubMed ID: 30609935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
    J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35-40 years.
    Tannus S; Turki R; Cohen Y; Son WY; Shavit T; Dahan MH
    Fertil Steril; 2017 Jun; 107(6):1323-1328.e2. PubMed ID: 28501366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High progesterone levels on the day after HCG injection has no effect on clinical pregnancy outcomes in
    Liang Z; Huang Q; Huang J; Wu J; Zeng D; Huang P
    Front Endocrinol (Lausanne); 2024; 15():1372753. PubMed ID: 38689731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrauterine administration of human chorionic gonadotropin does not improve pregnancy and life birth rates independently of blastocyst quality: a randomised prospective study.
    Wirleitner B; Schuff M; Vanderzwalmen P; Stecher A; Okhowat J; Hradecký L; Kohoutek T; Králícková M; Spitzer D; Zech NH
    Reprod Biol Endocrinol; 2015 Jul; 13():70. PubMed ID: 26141379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count.
    Ho VNA; Braam SC; Pham TD; Mol BW; Vuong LN
    Hum Reprod; 2019 Jun; 34(6):1055-1064. PubMed ID: 31111879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles.
    Law YJ; Zhang N; Venetis CA; Chambers GM; Harris K
    Hum Reprod; 2019 Sep; 34(9):1778-1787. PubMed ID: 31398253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study.
    Zhao F; Lan Y; Chen T; Xin Z; Liang Y; Li Y; Wang S; Zhang J; Yang X
    J Ovarian Res; 2020 Feb; 13(1):23. PubMed ID: 32113477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Serum estradiol the day of hCG administration as predictor factor of IVF-ET].
    Kably Ambe A; Estévez González S; Carballo Mondragón E
    Ginecol Obstet Mex; 2008 Apr; 76(4):197-201. PubMed ID: 18798418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.